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TO THE EDITOR
The peeling skin syndrome (PSS) is a rare
autosomal recessive group of genoder-
matoses characterized by an asympto-
matic, superficial exfoliation of the outer
epidermis, owing to a separation of the
stratum corneum from the stratum gran-
ulosum at the subcorneal level (Fox,
1921; Garcı´a et al., 2005). The onset of
the disease seems to be variable; most
patients develop their first symptoms
shortly after birth, but several cases with
onset in childhood or adulthood or after
the first pregnancy have been described
(Causeret et al., 2000).
Several types of PSS have been
described (Mevorah et al., 1987;
Traupe, 1989; Sardy et al., 2002; Judge
et al., 2004). The acral peeling skin
syndrome is a defined subtype (APSS,
MIM 609796) in which the peeling of
the skin is limited to the dorsa of the
hands and may be provoked by me-
chanical trauma or humidity (Shwayder
et al., 1997; Brusasco et al., 1998;
Hashimoto et al., 2000; Cassidy et al.,
2005). There are also cases in which
acral and generalized skin peeling
occur together (Ilknur et al., 2006).
Ultrastructural and light microscopic
studies in both the generalized and the
acral form of the disorder show the
same level of blistering in the epider-
mis, at the stratum granulosum–stratum
corneum junction.
The molecular cause of APSS was
elucidated in 2005, when Cassidy et al.
(2005) identified homozygous missense
mutations in the transglutaminase 5
gene (TGM5) in patients from two
independent Dutch and Scottish fami-
lies. In each of the six patients, they
identified two homozygous missense
mutations [p.T109M and p.G113C],
and showed by biochemical cross-
linking assays that only G113C com-
pletely abolished TGM5 activity,
whereas T109M was not found to be
pathogenic. No other groups have
confirmed these findings to date.
We report here the clinical and
genetic characteristics of two brothers
with APSS in a consanguineous
Tunisian family, in whom the diagnosis
was confirmed by ultrastructural and
histological analyses.
The first patient (P1) was a 5-year-
old Tunisian boy who presented focal
cutaneous exfoliation of the hands and
feet from the age of 3 years. The scaling
seemed to occur spontaneously, and
the patient was able to peel off sheets of
skin without pain. The symptoms were
exacerbated by elevated ambient
temperature, humidity, and friction.
The peeled areas show some residual
erythema for a few days but heal
spontaneously and without scarring
(Figure 1a). His 3-year-old brother (P2)
presented the same clinical features
(Figure 1b). The skin symptoms of both
patients were limited to the palmoplan-
tar regions and to the dorsa of the hands
and feet; the rest of the body was
normal. Our patients present the same
typical clinical features of acral PSS as
those described by Cassidy et al.
(2005), which affected predominantly
the dorsal parts of the hands and feet.
Family history included three other
affected individuals with similar clin-
ical features, but they were not avail-
able for examination and mutation
analysis. Apart from thalassemia minor
in patient 2, routine laboratory examina-
tions did not show any abnormalities.
Clinical data, pedigree information,
blood samples, and biopsies were
obtained after written informed con-
sent. DNA was extracted from periph-
eral blood leukocytes using standard
procedures. The study has been ap-
proved by the local Institutional Review
Board, and the Declaration of Helsinki
principles were respected.Abbreviations: PSS, peeling skin syndrome; TGM5, transglutaminase 5 gene
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Figure 1. Acral peeling skin syndrome and TGM5 mutations. (a) Peeling and erythema of the hands in patient 1: Superficial peeling of the skin of the hands
leaving residual, painless erythema. Manual skin removal is possible. (b) Superficial peeling of the skin and erythema of the foot in patient 2. (c) The cleavage is
located in the stratum corneum, mainly in the middle of the horny layer in the clear zone (scale bar¼ 500mm). (d) Cleavage in the stratum corneum (scale
bar¼ 80 mm). (e) Ultrastructural analysis shows separation at the junction between the granular cells and the stratum corneum in the outer epidermis (scale
bar¼ 3 mm). (f) Stratum granulosum: stellate and electron dense keratohyalin granules of various sizes were observed in the granular cells (scale bar¼ 0.5 mm). (g)
The sequence electropherogram shows the homozygous mutation (c.1335G4C; p.Lys445Asn) in both patients (P1 and P2); the mutation is heterozygous in the
mother, and the healthy control is homozygous for the wild type. (h) Protein modeling. Domains as indicated in the figure. The substituted amino acid,
asparagine 445, is shown in magenta, protruding toward an a-helix in the catalytic domain (indicated in white). The green circle indicates the original lysine
residue.
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A histological examination and
ultrastructural analysis may be helpful
for the diagnosis of PSS by confirming
the superficial level of the cleavage in
the epidermis showing a separation of
the stratum corneum just above the
level of the stratum granulosum (Silver-
man et al., 1986; Shwayder et al., 1997;
Hashimoto et al., 2000).
A histopathological examination of
skin biopsies from the border of a
palmar lesion showed a thickened
stratum corneum, but no acantholysis
or spongiosis. No abnormalities were
found in the spinous- and basal-cell
layers, and in the dermo–epidermal
junction. There was a cleavage located
in the stratum corneum, mainly in the
middle of the horny layer in the clear
zone (Figure 1c and d).
Ultrastructural studies in patient 1
showed enlarged intercellular spaces in
the stratum corneum (Figure 1e). Stellate
and electron dense keratohyalin granules
of various sizes were observed in the
granular cells (Figure 1f). These struc-
tures contained small ovoid electron-
lucent areas (Figure 1f). The keratin
filaments, the spinous and basal layers,
and the dermo-epidermal junction were
ultrastructurally normal. No desmosomal
abnormalities were observed, and the
cleavage occurred in the intercellular
spaces between corneocytes.
A genetic analysis was carried out in
patients and in both parents by direct
sequencing of all 12 exons and the
exon–intron boundaries of the TGM5
gene, using standard procedures. We
found a homozygous missense muta-
tion in exon 8 [c.1335G-C,
p.Lys445Asn (K445N)] in both patients,
P1 and P2; their parents, who were first
cousins, were both heterozygous for
this mutation (Figure 1g). The mutation
was not found in 120 healthy North-
African controls.
A three-dimensional homology mod-
el of TGM5 using TGM3 (PDB ID:
1I9mA, chain ID: A), which has 43%
sequence identity to TGM5 as a tem-
plate, was created using CLUSTALW2
(www.ebi.ac.uk/Tools/clustalw2/) align-
ment and the SWISS-MODEL server
(http://swissmodel.expasy.org) (Arnold
et al., 2006). The TGM5 catalytic
domain was approximated using the
best fit from an alignment between
TGM5 and TGM3; the results are
consistent with a three-dimensional
structure that suggests a catalytic do-
main between the N terminus and the
b-barrel domain 2, and in agreement
with earlier modeling results (Cassidy
et al., 2005). This three-dimensional
model of the TGM5 protein places the
p.Lys445Asn residue inside a function-
ally important catalytic domain (Figure
1h, white color), in which the aspar-
agine introduces extra bulk, putatively
disrupting local conformation.
The protein sequence alignment of
TGM5 from human, mouse, rat, dog,
cattle, and chimpanzee (Pan troglodytes)
further showed that the residue, 445
(lysine), is highly conserved between
these species (orthologs). It is also con-
served in all seven TGM paralogs (TGM1
to TGM7) (data not shown). Confirma-
tion of the role of TGM5 will require
further biochemical or quantitative ana-
lysis of enzyme activity in biopsy materi-
al, which is unavailable at this time.
As TGM5 is widely expressed in the
epidermis, it is surprising that acral PSS
affects only the dorsal regions of the
hands and feet (Candi et al., 2002).
Others have speculated that there may
be structurally important substrates ex-
pressed in these epidermal regions,
which are solely or preferentially
cross-linked by TGM5 (Cassidy et al.,
2005). Several different PSS phenotypes
have been reported in the literature,
such as generalized PSS (Fox, 1921;
Kurban and Azar, 1969; Abdel-Hafez
et al., 1983) or a localized continual
skin peeling limited to the facial skin in
a 6-month-old infant (Janjua et al.,
2007). As no TGM5 mutations have
been found in patients with generalized
PSS (Cassidy et al., 2005), it seems
evident that at least one other gene is
implicated in these phenotypes.
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Defensin Is Suppressed by Tick Salivary Gland Extract
During the In Vitro Interaction of Resident Skin Cells with
Borrelia burgdorferi
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TO THE EDITOR
The causative agent of Lyme disease,
Borrelia burgdorferi, is a spirochete
parasitizing vertebrates and transmitted
by the tick, Ixodes sp. Lyme disease is
the most common vector-borne disease
in the Northern Hemisphere (Piesman
and Gern, 2004). It manifests itself
frequently with an erythema migrans
rash at the site of the infection. How-
ever, the infection can progress and
disseminate, affecting other skin sites,
the joints, the heart, and the nervous
system in humans. Control of the initial
cutaneous phase may play a crucial
role in the outcome of the disease, as
not all patients develop disseminated
clinical infection (Steere and Glick-
stein, 2004).
The skin constitutes a complex
physical barrier. First, the epidermis
comprises mainly keratinocytes (KCs)
and Langerhans cells. These cells pos-
sess specific Toll-like receptors (TLRs)
that recognize certain defined patterns,
the pathogen-associated molecular pat-
terns, present on pathogens. The inter-
action between pathogen-associated
molecular patterns and TLRs leads to
the activation of the NF-kB pathway,
with the production of inflammatory
molecules including chemokines, cyto-
kines, and antimicrobial peptides
(AMPs) (Pivarcsi et al., 2004). These
molecules of innate immunity are
essential to the control of infection.
Dermal fibroblasts (FBs) constitute a
second group of resident skin cells that
secrete the extracellular matrix and
communicate with other cell types such
as dermal dendritic cells, mast cells,
macrophages, and KCs (Sorrell and
Caplan, 2004).
Ebnet et al. (1997) reported the
activation of NF-kB upon the inter-
action of Borrelia with human KCs and
FBs. However, no recent study has
investigated the potential induction of
AMPs in the interaction of B. burgdor-
feri with resident skin cells. We studied
the induction of the proinflammatory
molecule IL-8, defensins, and catheli-
cidin. IL-8 is a chemokine that attracts
neutrophils, major cells involved in
inflammation and secreting AMPs. De-
fensins are produced by leukocytes and
various epithelial cells (Ganz, 2003).
The cathelicidin LL-37, in humans, is
present constitutively in neutrophil
granules and is inducible in epithelial
cells in response to infection. Their role
in the control of several skin inflamma-
tions is well established (Nizet et al.,
2001; Ong et al., 2002; Braff et al.,
2005). We used ELISA to measure the
secretion of IL-8 and HBD-2 (human b-
defensin-2) and quantitative real-time
reverse transcriptase-PCR to study the
induction of HBD-2 and LL-37 mRNAs
by KCs and FBs. IL-8 was induced by B.
burgdorferi in a dose-dependent man-
ner in KCs and FBs (Figure 1a and b).
Regarding AMP mRNAs, defensin, but
not cathelicidin, was induced in KCs
(Figure 1c and f). In FBs, Borrelia did
not induce HBD-2 and a weak expres-
sion of LL-37 mRNA was observed
(Figure 1d and f). A kinetic study
revealed that IL-8 secretion reached its
highest level at 12 hours for both KCs
and FBs (Figure 1g and h), whereas
HBD-2 mRNA reached a peak at
6 hours in KCs (Figure 1i), also con-
firmed by the measure of HBD-2
secretion by ELISA (data not shown).
Only very weak amounts were found to
be secreted by FBs upon stimulation
with Borrelia (Figure 1j). For LL-37
mRNA, only marginal expression by
KCs was shown (Figure 1k), whereas
Borrelia elicited a much higher expres-
sion in FBs, which peaked at 6 hours
(Figure 1l). As Borrelia are transmitted
by the Ixodes tick, we analyzed the
effect of tick salivary gland (SG) extract
on host cell inflammation. As can be
seen in Figure 2, induction of IL-8 and
HBD-2 was significantly inhibited by
SG extract. The inhibitory effect on IL-8
Abbreviations: AMP, antimicrobial peptide; FB, fibroblast; HBD, human b-defensin; KC, keratinocyte;
SG, salivary gland; TLR, Toll-like receptor
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